SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-300692
Filing Date
2014-08-07
Accepted
2014-08-07 16:12:18
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d760312d10q.htm 10-Q 536765
2 EX-31.1 d760312dex311.htm EX-31.1 6249
3 EX-31.2 d760312dex312.htm EX-31.2 5981
4 EX-32.1 d760312dex321.htm EX-32.1 4370
  Complete submission text file 0001193125-14-300692.txt   2943947

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20140630.xml EX-101.INS 285641
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20140630.xsd EX-101.SCH 37851
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20140630_cal.xml EX-101.CAL 48755
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20140630_def.xml EX-101.DEF 116819
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20140630_lab.xml EX-101.LAB 266324
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20140630_pre.xml EX-101.PRE 186726
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 141024065
SIC: 2834 Pharmaceutical Preparations